fingolimod hydrochloride has been researched along with Liver Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chun, J; Cohen, JA | 1 |
| David, OJ; Kovarik, JM; Schmouder, RL | 1 |
| He, JH; Lin, ZB; Zhang, HN | 1 |
| Dilzer, SC; Kovarik, JM; Lasseter, KC; Schmouder, RL; Serra, D; Wang, Y; Wiegand, H | 1 |
2 review(s) available for fingolimod hydrochloride and Liver Diseases
| Article | Year |
|---|---|
Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.
Topics: Animals; Central Nervous System; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Disease Models, Animal; Fingolimod Hydrochloride; Heart Diseases; Humans; Immunosuppressive Agents; Infections; Liver Diseases; Lymphocytes; Lysophospholipids; Multiple Sclerosis; Propylene Glycols; Receptors, Lysosphingolipid; Respiration Disorders; Sphingosine | 2011 |
Clinical pharmacokinetics of fingolimod.
Topics: Animals; Blood Proteins; Drug Interactions; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Kidney Diseases; Liver Diseases; Multiple Sclerosis; Propylene Glycols; Protein Binding; Sphingosine | 2012 |
2 other study(ies) available for fingolimod hydrochloride and Liver Diseases
| Article | Year |
|---|---|
Effect of 2-amino-2-(2-(4-octylphenyl) ethyl) propane-1,3-diol hydrochloride (FTY 720) on immune liver injury in mice.
Topics: Acute Disease; Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Cell Division; Concanavalin A; Fingolimod Hydrochloride; Hepatocytes; Immunosuppressive Agents; Interferon-gamma; Interleukin-4; Lipopolysaccharides; Liver Diseases; Male; Mice; Mycobacterium bovis; Propylene Glycols; Rats; Rats, Wistar; Sphingosine; Spleen | 2005 |
FTY720 pharmacokinetics in mild to moderate hepatic impairment.
Topics: Case-Control Studies; Female; Fingolimod Hydrochloride; Humans; Liver Diseases; Male; Middle Aged; Propylene Glycols; Sphingosine | 2005 |